143 related articles for article (PubMed ID: 7669384)
1. Adrenal 21-hydroxylase deficiency in childhood: 25 years' experience.
Lim YJ; Batch JA; Warne GL
J Paediatr Child Health; 1995 Jun; 31(3):222-7. PubMed ID: 7669384
[TBL] [Abstract][Full Text] [Related]
2. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
Weintrob N; Dickerman Z; Sprecher E; Galatzer A; Pertzelan A
Eur J Endocrinol; 1997 Feb; 136(2):188-95. PubMed ID: 9116914
[TBL] [Abstract][Full Text] [Related]
3. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
Muirhead S; Sellers EA; Guyda H;
J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
[TBL] [Abstract][Full Text] [Related]
4. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
Premawardhana LD; Hughes IA; Read GF; Scanlon MF
Clin Endocrinol (Oxf); 1997 Mar; 46(3):327-32. PubMed ID: 9156043
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Forest MG
Hum Reprod Update; 2004; 10(6):469-85. PubMed ID: 15514016
[TBL] [Abstract][Full Text] [Related]
6. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[TBL] [Abstract][Full Text] [Related]
7. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
Lemos-Marini SH; Guerra-Júnior G; Morcillo AM; Baptista MT; Silva LO; Maciel-Guerra AT
Arq Bras Endocrinol Metabol; 2005 Dec; 49(6):902-7. PubMed ID: 16544012
[TBL] [Abstract][Full Text] [Related]
8. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J; Aldridge S; Thomas M; Cheetham T
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1019-1022. PubMed ID: 30173205
[TBL] [Abstract][Full Text] [Related]
9. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
10. Gender dichotomy in long term growth trajectories of children with 21-hydroxylase deficiency congenital adrenal hyperplasia.
Patel L; Chandrashekhar SR; Gemmell I; O'Shea E; Jones J; Banerjee I; Amin R; Clayton P
Horm Res Paediatr; 2011; 75(3):206-12. PubMed ID: 20962509
[TBL] [Abstract][Full Text] [Related]
11. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
Juan L; Huamei M; Zhe S; Yanhong L; Hongshan C; Qiuli C; Jun Z; Song G; Minlian D
J Pediatr Endocrinol Metab; 2016 Jul; 29(7):841-8. PubMed ID: 27054598
[TBL] [Abstract][Full Text] [Related]
12. Congenital adrenal hyperplasia in the Bahamas due to 21-hydroxylase deficiency.
Peter S; McDigean G; Sandiford P; Smith T
West Indian Med J; 2006 Mar; 55(2):110-2. PubMed ID: 16921705
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
Van der Kamp HJ; Otten BJ; Buitenweg N; De Muinck Keizer-Schrama SM; Oostdijk W; Jansen M; Delemarre-de Waal HA; Vulsma T; Wit JM
Arch Dis Child; 2002 Aug; 87(2):139-44. PubMed ID: 12138066
[TBL] [Abstract][Full Text] [Related]
14. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
[TBL] [Abstract][Full Text] [Related]
15. Growth Pattern and Clinical Profile of Indian Children with Classical 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia on Treatment.
Meena H; Jana M; Singh V; Kabra M; Jain V
Indian J Pediatr; 2019 Jun; 86(6):496-502. PubMed ID: 30697677
[TBL] [Abstract][Full Text] [Related]
16. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Gasparini N; Di Maio S; Salerno M; Argenziano A; Franzese A; Tenore A
Horm Res; 1997; 47(1):17-22. PubMed ID: 9010713
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF; Charmandari E; Dattani MT; Hindmarsh PC
Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
Stikkelbroeck NM; Van't Hof-Grootenboer BA; Hermus AR; Otten BJ; Van't Hof MA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
[TBL] [Abstract][Full Text] [Related]
19. Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis.
Eugster EA; Dimeglio LA; Wright JC; Freidenberg GR; Seshadri R; Pescovitz OH
J Pediatr; 2001 Jan; 138(1):26-32. PubMed ID: 11148508
[TBL] [Abstract][Full Text] [Related]
20. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.
Balsamo A; Cicognani A; Baldazzi L; Barbaro M; Baronio F; Gennari M; Bal M; Cassio A; Kontaxaki K; Cacciari E
J Clin Endocrinol Metab; 2003 Dec; 88(12):5680-8. PubMed ID: 14671153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
